• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

DF/HCC News

    First trial of multi-targeted inhibitor in patients with metastatic colorectal cancer

    Although the median survival rate for patients with metastatic colorectal cancer has doubled over the past decade, it remains only about 24 months

    DF/HCC Skin SPORE renewed

    The DF/HCC Skin SPORE, led by Thomas Kupper, MD (BWH), has been highly successful in creating cohesion in the Cutaneous Oncology and Melanoma program, sparking new collaborative grants, fostering innovative ideas in cancer research, and advancing the careers of junior investigators

    DF/HCC members awarded grants amid tight funding environment

    The NIH continues to recognize DF/HCC as a leader in cancer research by awarding funding to a number of our research initiatives

    Raynard S. Kington named NIH Acting Director
    Thinking therapeutically: Scientists in search of smarter tests and treatments for prostate cancer

    Even though prostate cancer is the second leading cause of cancer death in men in the United States, some patients may wonder whether treatment is worse than the disease

Displaying results 31 to 35 out of 116

< Previous

1

2

3

4

5

6

7

Next >